Long-term results from INT-HER study: Retrospective evaluation of adjuvant trastuzumab in unselected HER2-positive breast cancer patients—Single institution experience.

Real world data on adjuvant treatment of older HER2-positive breast cancer patients - a single institution experience through 8 years

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2021.100430 ◽

2021 ◽

pp. 100430

Author(s):

L Klint ◽

A Kovács ◽

E Rönnerman ◽

B Linderholm

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Real World ◽

Breast Cancer Patients ◽

Single Institution ◽

Her2 Positive ◽

Real World Data ◽

226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study

Annals of Oncology ◽

10.1016/j.annonc.2020.08.347 ◽

2020 ◽

Vol 31 ◽

pp. S331

Author(s):

C. Molinelli ◽

L. Del Mastro ◽

S. Giraudi ◽

A. Ballestrero ◽

F. Carli ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Cardiac Safety ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Abstract P5-10-18: The chromosomal genomic landscape and targetable co-amplified genes in HER2 positive breast cancer patients who relapsed on an adjuvant trastuzumab chemotherapy trial

10.1158/1538-7445.sabcs14-p5-10-18 ◽

2015 ◽

Author(s):

Shelly Gunn ◽

Chris McCaskill ◽

Linda Daley ◽

Agnes Puskas ◽

Lina Asmar ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Genomic Landscape ◽

The impact of the loco-regional treatment in elderly breast cancer patients: Hypo-fractionated exclusive radiotherapy, single institution long-term results

The Breast ◽

10.1016/j.breast.2010.04.004 ◽

2010 ◽

Vol 19 (5) ◽

pp. 413-416 ◽

Cited By ~ 10

Author(s):

Cyrus Chargari ◽

Youlia M. Kirova ◽

Fatima Laki ◽

Alexia Savignoni ◽

Thierry Dorval ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Long Term Results ◽

Breast Cancer Patients ◽

Single Institution ◽

The Impact ◽

Regional Treatment

Clinical Outcome of HER2-positive Breast Cancer Patients after Failure on Adjuvant Trastuzumab: The Potential of the Time to Relapse

Clinical Oncology ◽

10.1016/j.clon.2013.11.028 ◽

2014 ◽

Vol 26 (3) ◽

pp. 174

Author(s):

S. Di Cosimo ◽

D. Serpico ◽

L. Porcu ◽

L. Molino ◽

G. Fanetti ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Outcome ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Time To Relapse ◽

Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab

Breast Cancer ◽

10.1007/s12282-013-0478-y ◽

2013 ◽

Vol 22 (3) ◽

pp. 292-299 ◽

Cited By ~ 9

Author(s):

Junichi Kurebayashi ◽

Naoki Kanomata ◽

Tetsumasa Yamashita ◽

Toshiro Shimo ◽

Akiko Mizutoh ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Prognostic Value ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

PO58 DOES PREVIOUS NEOADJUVANT/ADJUVANT TRASTUZUMAB INFLUENCE THE DISEASE OUTCOME OF METASTATIC HER2 POSITIVE BREAST CANCER PATIENTS TREATED WITH FIRST LINE TRASTUZUMAB AND CHEMOTHERAPY

The Breast ◽

10.1016/s0960-9776(15)30070-9 ◽

2015 ◽

Vol 24 ◽

pp. S41-S42

Author(s):

Snezana Milosevic ◽

Nemanja Stanic ◽

Ivana Bozovic-Spasojevic ◽

Zorica Tomasevic ◽

Snezana Susnjar

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Disease Outcome ◽

Breast Cancer Patients ◽

First Line ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Primary trastuzumab-resistance after (neo)adjuvant trastuzumab-containing treatment for HER2-positive breast cancer patients in real-world practice

Clinical Breast Cancer ◽

10.1016/j.clbc.2020.09.003 ◽

2020 ◽

Author(s):

Xuelian Chen ◽

Jiayu Wang ◽

Ying Fan ◽

Yang Luo ◽

Pin Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Real World ◽

Breast Cancer Patients ◽

Trastuzumab Resistance ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Adjuvant Trastuzumab Therapy In Her2-Positive Breast Cancer Patients: A Meta-Analysis Of Published Randomized Trials

Value in Health ◽

10.1016/j.jval.2013.03.622 ◽

2013 ◽

Vol 16 (3) ◽

pp. A128

Author(s):

Y. Xia ◽

B. Bian ◽

E. Costea ◽

C.M. Kelton ◽

J.J. Guo

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Randomized Trials ◽

Meta Analysis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Trastuzumab Therapy ◽

Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab

American Journal of Clinical Pathology ◽

10.1309/ajcp51hcgpopwscy ◽

2015 ◽

Vol 144 (4) ◽

pp. 570-578 ◽

Cited By ~ 31

Author(s):

Hee Jin Lee ◽

Joo Young Kim ◽

So Yeon Park ◽

In Ah Park ◽

In Hye Song ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Gene Amplification ◽

Breast Cancer Patients ◽

Her2 Gene ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Her2 Gene Amplification ◽